Literature DB >> 28414120

The predictive value of integrated inflammation scores in the survival of patients with resected hepatocellular carcinoma: A Retrospective Cohort Study.

Shuo Pang1, Ziquan Zhou1, Xingchen Yu1, Shaozhong Wei2, Qiongrong Chen3, Shaofa Nie1, Xinjun Liang4, Li Liu5.   

Abstract

BACKGROUND: Evidence supports the predictive potential of inflammatory marker-derived scores (inflammation scores) and hepatitis B virus (HBV) infection on prognosis of patients with hepatocellular carcinoma (HCC). However, no study has longitudinally assessed the predictive values of inflammation scores combined with hepatitis B virus status on survival of these patients. Therefore, a study was designed to evaluate the prognostic capacity of preoperative, dynamic changes in integrated scores, through a combination of general inflammation scores and HBV infection status, on HCC patients undergoing tumor resection.
METHODS: The clinicopathological data of 247 patients with primary HCC who underwent liver resection were collected. Inflammation-related laboratory examinations were performed 1 week before operation, and 1 week, 1 month, 3months, and 6months after operation. The prognostic values of preoperative and dynamic changes in integrated inflammation scores were studied using the Cox regression models.
RESULTS: Elevated preoperative integrated inflammation scores, including co-Glasgow prognostic score (coGPS), co-modified Glasgow prognostic score (comGPS), co-C reactive protein to albumin ratio (coCRP/ALB), co-prognostic index (coPI), co-neutrophil to lymphocyte ratio (coNLR), co-lymphocyte to monocyte ratio (coLMR), coNLR-PLR and coCRP/ALB-PLR, were associated with decreased overall survival (OS). Dynamic changes in coGPS, comGPS, coCRP/ALB, coPI, coPLR, coNLR, coSII, coNLR-PLR, and coCRP/ALB-PLR were independent prognostic factors of OS. coCRP/ALB-PLR was significantly associated with disease free survival.
CONCLUSIONS: Preoperative and dynamic changes in integrated inflammation scores, particularly for coCRP/ALB-PLR were important and stable prognostic markers in HCC.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Dynamic change; Hepatocellular carcinoma; Inflammation score; Prognosis

Mesh:

Substances:

Year:  2017        PMID: 28414120     DOI: 10.1016/j.ijsu.2017.04.018

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  7 in total

1.  Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer.

Authors:  Zi-Quan Zhou; Shuo Pang; Xing-Chen Yu; Qi Xue; Hong-Yu Jiang; Xin-Jun Liang; Li Liu
Journal:  Curr Med Sci       Date:  2018-10-20

2.  Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma.

Authors:  Xiao Fu; Yixuan Yang; Dazhi Zhang
Journal:  Liver Int       Date:  2021-12-07       Impact factor: 8.754

3.  Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Authors:  Hongyu Wang; Chuyang Lin; Wenzhe Fan; Jiang Zhang; Yingqiang Zhang; Wang Yao; Jiaping Li
Journal:  Cancer Manag Res       Date:  2020-05-14       Impact factor: 3.989

4.  Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio.

Authors:  Linda Wong; Kliment Bozhilov; Brenda Hernandez; Sandi Kwee; Owen Chan; Luke Ellis; Loic LeMarchand
Journal:  Clin Mol Hepatol       Date:  2019-04-19

Review 5.  Biomarkers for Evaluating the Inflammation Status in Patients with Cancer.

Authors:  Ali Guner; Hyoung-Il Kim
Journal:  J Gastric Cancer       Date:  2019-09-09       Impact factor: 3.720

6.  Association Between Intermediate-Acting Neuromuscular-Blocking Agents and Short-Term Postoperative Outcomes in Patients with Gastric Cancer.

Authors:  Lingxia Niu; Chunlin Yao; Yu Wang; Yan Sun; Juan Xu; Yun Lin; Shanglong Yao
Journal:  Cancer Manag Res       Date:  2020-11-06       Impact factor: 3.989

Review 7.  Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Nanping Lin; Jingrong Li; Qiao Ke; Lei Wang; Yingping Cao; Jingfeng Liu
Journal:  Dis Markers       Date:  2020-09-02       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.